A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.
Manufactured by
China
Xenta Biomedical Science Co., Ltd, founded in December 2021 and headquartered in Guangzhou Development District, is a national high-tech enterprise focused on the R&D, registration, and commercialization of in vitro diagnostic (IVD) reagents and devices. With fully paid-up capital of RMB 10 million, the company is led by a team of returnee PhDs with strong international research and industry experience. It is dedicated to developing innovative POCT technology platforms under the philosophy of "Faster, Better, and More Accessible". The company drives innovation through R&D centers in Guangzhou, Xiamen, and overseas. Using its proprietary dry light-excited chemiluminescence POCT platform, it has developed leading product series and managed major national research projects. The company has published over 20 SCI papers, holds 70 patents, has obtained more than 60 EU CE certifications, and 12 FDA approvals in the United States. Currently, several product lines are actively striving for NMPA certification. Its pipeline covers key areas including cardiovascular, inflammation, oncology, hormone, and infectious diseases, demonstrating end-to-end capabilities from R&D to global commercialization. The core team comprises graduates from top universities such as Texas A&M University, Xiamen University, Sanford-Burnham Medical Research Institute, and Sun Yat-sen University, possessing multidisciplinary expertise in biomedicine, engineering, and law. The co-founders have extensive experience from leading IVD companies, having previously guided teams to achieve annual revenues exceeding several hundred million yuan and secure over 200 product certifications worldwide. Since its establishment, Xenta Biomedical Science Co., Ltd has raised tens of millions in funding and obtained ISO 13485 certification, supporting its global expansion.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hangzhou DALTON BioSciences, Ltd.
China · 4 relevant products
Advanced Molecular Diagnostics Ltd.
United Kingdom · 4 relevant products
Igenesis(Shanghai)Co.Ltd.
China · 3 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 10 relevant products
ACON Laboratories, Inc.
United States · 3 relevant products
GUANGZHOU BIOTRON TECHNOLOGY CO., LTD.
China · 3 relevant products
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
China · 6 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 4 relevant products
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 1 relevant product
BioTeke Corporation(wuxi) Co.,Ltd
China · 1 relevant product
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 112 closest product alternatives
Hangzhou DALTON BioSciences, Ltd. · China
A diagnostic test kit detecting 18 types of human papillomavirus including 14 high-risk types recognized by WHO as causative agents of cervical cancer and 4 medium-risk types associated with cervical cancer, using hybrid capture-chemiluminescence method.
Hangzhou DALTON BioSciences, Ltd. · China
Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.
Advanced Molecular Diagnostics Ltd. · United Kingdom
Molecular detection kit for high-risk HPV types 16 and 18. Supports cervical cancer screening and risk stratification.
Advanced Molecular Diagnostics Ltd. · United Kingdom
CE-IVD marked qPCR detection kit for identification of Human Papillomavirus types 16 and 18 in clinical samples. Enables rapid molecular diagnosis of high-risk HPV strains associated with cervical and anogenital cancers. Suitable for use in clinical laboratories and diagnostic facilities performing HPV screening and risk stratification.
Igenesis(Shanghai)Co.Ltd. · China
A PCR fluorescence probe method diagnostic kit for detecting 16 high-risk human papillomavirus types and genotyping HPV 16 and 18. The kit provides 6-plex detection with internal control and is designed for use with the Galaxy Nano system.
Advanced Molecular Diagnostics Ltd. · United Kingdom
CE-IVD marked qPCR detection kit for identification of Human Papillomavirus types 6 and 11 in clinical samples. Enables rapid molecular diagnosis of HPV infection using quantitative PCR methodology. Designed for use in clinical and diagnostic laboratories for cervical screening and infection detection.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.
ACON Laboratories, Inc. · United States
A nucleic acid-based PCR test kit for genotyping of human papillomavirus. Provides comprehensive identification of HPV strains for clinical assessment.
GUANGZHOU BIOTRON TECHNOLOGY CO., LTD. · China
HPV 15 genotype detection kit using fluorescence PCR melting curve analysis for identifying human papillomavirus types in clinical specimens. Enables rapid, simultaneous detection and differentiation of multiple HPV genotypes relevant to cervical cancer screening and risk stratification.
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. · China
In vitro qualitative detection kit for 18 types of high-risk HPV using fluorescence PCR technology. Suitable for urine, cervical swab, and vaginal swab samples with HPV 16/18 typing capability. CE and TFDA approved for clinical diagnostic use.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
Comprehensive HPV genotyping kit detecting 23 distinct human papillomavirus types including 18 high-risk and 5 low-risk strains. Enables accurate HPV infection characterization for clinical management.
HLB PANAGENE Co., Ltd. · South Korea
A comprehensive HPV genotyping assay for detection and identification of human papillomavirus types in cervical and other samples.
100 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products